Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 41Sarcoma 33Genitourinary 12Gynecologic 9CNS 8Other hematologic neoplasm 6Tumor-Agnostic 1Plasma cell 1Head & Neck 1Gastrointestinal 1Dermatologic 1Classical hematology 1Breast 1

Conditions

Thrombocytopenia 1

Interventions

Cyclophosphamide 37fludarabine phosphate 35Mycophenolic Acid 33Whole-Body Irradiation 32Busulfan 24Tacrolimus 22fludarabine 21Peripheral Blood Stem Cell Transplantation 20Cyclosporine 20Melphalan 17Antilymphocyte Serum 13Methotrexate 12Filgrastim 12Granulocyte Colony-Stimulating Factor 11Cytarabine 11Cord Blood Stem Cell Transplantation 11Thiotepa 9thymoglobulin 8eltrombopag 8Lenalidomide 7Etoposide 7Epoetin Alfa 7Dalteparin 7romiplostim 6Darbepoetin alfa 6Alemtuzumab 6merphos 5apixaban 5Sirolimus 5Radiotherapy 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Ifosfamide × Classical hematology × Clear all
NCT00147225 2014-05-08

AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin

M.D. Anderson Cancer Center

Phase 1/2 Completed
55 enrolled 11 charts
Classical hematology

Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡